Rosvin F

Backed with a team of experienced professionals, we are engaged in exporting, manufacturing and supplying of rosvin F in Mumbai, Maharashtra, India. Mixed dyslipidaemia among patients with metabolic syndrome or diabetes mellitus is very common. Diabetic dyslipidaemia is characterized by increased low-density lipoprotein cholesterol (LDL-C), elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C), is associated with an increased risk of coronary artery disease (CAD). Rosuvastatin in Rosvin- F significantly reduces LDL-C & increase HDL. Fenofibrate reduces triglycerides level and increases HDL level. Thus, the combination of rosuvastatin and fenofibrate offers an improved and effective therapeutic option in the management of diabetic dyslipidemia.